Trial record 1 of 1 for:    NCT01237067
Previous Study | Return to List | Next Study

Olaparib in Combination With Carboplatin for Refractory or Recurrent Women s Cancers

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01237067
Recruitment Status : Completed
First Posted : November 9, 2010
Last Update Posted : January 19, 2018
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Cancer Institute (NCI) )